⌘K

t

RNS Metadata

Date	23 Sept 2021
Time	07:00:08
Category	Miscellaneous
ID	6834M

/Equities/XLON/AZN/RNS

Board Committee Change

RNS Number : 6834M

AstraZeneca PLC

23 September 2021

23 September 2021 07:00 BST

Science Committee appointment

AstraZeneca PLC announced today that the Board has appointed Diana Layfield as a member of the Science Committee, with effect from 1 October 2021.

AstraZeneca

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.

Contacts

For details on how to contact the Investor Relations Team, please click here. For Media contacts, click here.

Adrian Kemp
Company Secretary

AstraZeneca PLC

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCPPUBUBUPGGBP

RNS Metadata

Date	23 Sept 2021
Time	07:00:08
Category	Miscellaneous
ID	6834M

RNS Number : 6834M

AstraZeneca PLC

23 September 2021

23 September 2021 07:00 BST

Science Committee appointment

AstraZeneca PLC announced today that the Board has appointed Diana Layfield as a member of the Science Committee, with effect from 1 October 2021.

AstraZeneca

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.

Contacts

For details on how to contact the Investor Relations Team, please click here. For Media contacts, click here.

Adrian Kemp
Company Secretary

AstraZeneca PLC

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCPPUBUBUPGGBP

TIDM	AZN
Share Price	Loading...
Market Cap	Loading...

TIDM	AZN
Share Price	Loading...
Market Cap	Loading...

t

t

Company Information

RNS Metadata

Board Committee Change

Company Information

RNS Metadata